Three Directors at BioArctic AB bought 3,120 shares at between 163.200SEK and 164.700SEK. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...
We expect another soft quarter (7.8% organic revenue growth YOY and a 27.5% EBIT margin), before then improving. We look for unchanged 2024/25 guidance of 8–9% organic sales growth and a c28% EBIT margin before special items. We have cut our 2024/25–2026/27e EPS by 2.8% on average and believe returning to a 30%+ EBIT margin hinges on external factors. We reiterate our HOLD, but have cut our target price to DKK770 (850).
Coloplast A/S - H1 2024/25 Earnings Release - Invitation to conference call on 6 May 2025 at 11.00am CEST Tuesday, 6 May 2025 at 11.00 - 12.00am CESTIn connection with the publication of Coloplast’s interim financial results for H1 2024/25, to be released same day around 07.30am CEST, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.The webcast of the conference call will be available during and after the e...
The recent announcement of the application of trade tariffs by the Trump administration led to a sharp correction in oil prices amidst fears of an economic slowdown as a result of a full-blown trade war. We are adopting a more cautious scenario, with oil prices now expected to reach $ 67/b for 2025, $ 65/b for 2026 and $ 67/b in the longer term. Our 2025-2030 capex scenario has been lowered by 5% and our EPS expectations by 13% on average over 2025-2027, whilst our target prices have been lowere...
La récente annonce de mise en place de droits de douanes par l’administration Trump a entraîné une vive correction des cours du pétrole sur fond de crainte de ralentissement économique à la suite d’une véritable guerre commerciale. Nous adoptons un scenario plus prudent avec un baril désormais attendu respectivement à 67 $ sur2025, 65 $ 2026 et 67 $ sur le LT. Notre scénario de Capex 2025/30 a été abaissé de 5% et nos attentes de BPA de 13% en moyenne sur 2025/27 et nos OC de 10%. Nous privilégi...
Equinor ASA: proposal on capital reduction from the company’s board of directors The board of directors of Equinor ASA (OSE: EQNR, NYSE: EQNR) has today decided to propose to the general meeting of the company that the company’s share capital is reduced through cancellation of own shares and redemption of shares belonging to the Norwegian State. The proposal is made as a result of the company having acquired own shares pursuant to the authorization for share buy-back granted by the annual general meeting of the company in May 2024. The proposal entails that the company's share capital shal...
Equinor ASA: forslag om kapitalnedsettelse fra selskapets styre Styret i Equinor ASA (OSE: EQNR, NYSE: EQNR) har i dag besluttet å foreslå for selskapets generalforsamling at selskapets aksjekapital nedsettes ved sletting av egne aksjer og innløsning av aksjer tilhørende den norske stat. Forslaget fremsettes som følge av at selskapet har gjennomført tilbakekjøp av egne aksjer i henhold til fullmakt for tilbakekjøp gitt av selskapets generalforsamling i mai 2024. Forslaget går ut på at selskapets aksjekapital skal nedsettes med NOK 589.934.295 fra NOK 6.981.953.075,00 til NOK 6.392.018.780,...
We have stress-tested our coverage universe at a USD60/bbl oil price, concluding that most names remain dependent on rising oil prices to warrant upside potential from current share prices. Moreover, unless oil prices move higher, we see increasing risk of cuts in shareholder distributions for Vår Energi and Equinor, while the risk appears lower for Aker BP. Overall, we remain cautious as macro risks remain tilted to the downside. We continue to prefer Aker BP as it screens best on valuation and...
This week, Equinor, Aker BP, and Vår Energi released their Q1 trading updates. Equinor’s realised liquids prices were broadly in line with consensus across all segments. Aker BP reported a modest production beat, 2% above consensus, with realised liquids and gas prices largely as expected. Vår Energi’s Q1 production was 2% below our estimate and consensus, while realised liquids prices met expectations and gas prices exceeded them by 4–11%.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.